These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16939546)

  • 1. Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey.
    Lidove O; Ramaswami U; Jaussaud R; Barbey F; Maisonobe T; Caillaud C; Beck M; Sunder-Plassmann G; Linhart A; Mehta A;
    Int J Clin Pract; 2006 Sep; 60(9):1053-9. PubMed ID: 16939546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fabry disease: demographic data since introduction of enzyme replacement therapy].
    Cybulla M; Walter K; Neumann HP; Widmer U; Schärer M; Sunder-Plassmann G; Jansen T; Rolfs A; Beck M
    Dtsch Med Wochenschr; 2007 Jul; 132(28-29):1505-9. PubMed ID: 17607649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
    Hegemann S; Hajioff D; Conti G; Beck M; Sunder-Plassmann G; Widmer U; Mehta A; Keilmann A
    Eur J Clin Invest; 2006 Sep; 36(9):654-62. PubMed ID: 16919049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
    Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
    Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS).
    Barba-Romero MÁ; Rivera-Gallego A; Pintos-Morell G;
    Int J Clin Pract; 2011 Aug; 65(8):903-10. PubMed ID: 21679285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
    Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
    Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.
    Hopkin RJ; Bissler J; Banikazemi M; Clarke L; Eng CM; Germain DP; Lemay R; Tylki-Szymanska A; Wilcox WR
    Pediatr Res; 2008 Nov; 64(5):550-5. PubMed ID: 18596579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does geographical location influence the phenotype of Fabry disease in women in Europe?
    Barba-Romero MA; Deegan P; Giugliani R; Hughes D
    Clin Genet; 2010 Feb; 77(2):131-40. PubMed ID: 20096069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease.
    Tavakoli M; Marshall A; Thompson L; Kenny M; Waldek S; Efron N; Malik RA
    Muscle Nerve; 2009 Dec; 40(6):976-84. PubMed ID: 19902546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiari type I malformation in four unrelated patients affected with Fabry disease.
    Germain DP; Benistan K; Halimi P
    Eur J Med Genet; 2006; 49(5):419-25. PubMed ID: 16510324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misdiagnosis in Fabry disease.
    Marchesoni CL; Roa N; Pardal AM; Neumann P; Cáceres G; Martínez P; Kisinovsky I; Bianchi S; Tarabuso AL; Reisin RC
    J Pediatr; 2010 May; 156(5):828-31. PubMed ID: 20385321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold capillaroscopy: Specific features in Fabry disease.
    Wasik JS; Simon RW; Meier T; Steinmann B; Amann-Vesti BR
    Clin Hemorheol Microcirc; 2009; 42(2):99-106. PubMed ID: 19433883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal extremity pain as a presenting feature of Fabry's disease.
    Pagnini I; Borsini W; Cecchi F; Sgalambro A; Olivotto I; Frullini A; Cimaz R
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):390-5. PubMed ID: 20981813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplant outcomes in patients with Fabry disease.
    Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
    Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
    Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients.
    Walling HW
    J Am Acad Dermatol; 2009 Aug; 61(2):242-6. PubMed ID: 19395123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry disease in Argentina: an evaluation of patients enrolled in the Fabry Registry.
    Politei JM; Cabrera G; Amartino H; Valdez R; Masllorens F; Ripeau D; Antongiovanni N; Soliani A; Luna P; Cedrolla M; Fernandez S; Fainboim A
    Int J Clin Pract; 2013 Jan; 67(1):66-72. PubMed ID: 23241050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study.
    Sadick N; Thomas L
    Heart Lung Circ; 2007 Jun; 16(3):200-6. PubMed ID: 17452128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.